NYtor, partner in smart molecular diagnostic assay development! NYtor designs and develops smart molecular detection assays for a broad range of applications, in collaboration with different partners. Our strength lies in the development of qPCR and point-of-care assays with main focus on the detection of pathogens and their antibiotic resistance and on early cancer screening.
| Website | https://www.nytor.nl/ |
| Employees | 8 (5 on RocketReach) |
| Founded | 2007 |
| Technologies | |
| Industry | Biotechnology Research |
| Keywords | Molecular Diagnostics, Assay Development, Diagnostic Assays, Biotechnology, Life Sciences, In Vitro Diagnostics, Medical Devices, Research And Development, Diagnostic Tools, Molecular Testing, Clinical Diagnostics, Lab Diagnostics, Healthcare Technology, Precision Medicine, Personalized Medicine, Diagnostic Solutions, Scientific Research |
| Competitors | Leupold + Stevens, Inc., Vortex Optics, Trijicon, Inc., Primary Arms, LLC, Burris Company, Inc, American Technologies Network, Corp., Aimpoint AB, Electro Optics Technology, NcSTAR, Sightmark Optics +39 more (view full list) |
Looking for a particular NYtor employee's phone or email?
Han Zendman is the CEO of NYtor.
5 people are employed at NYtor.